Metraipolis › archive › dc_ea5917e3ecb0

Modulatory efficacy of bone metabolism and safety of denosumab versus zoledronic acid in the treatment of bone and joint osteoporosis in elderly men — Europe PMC PMID:41208862

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41208862
DOI
10.3389/fphar.2025.1666421
License (as archived)
solo-consultazione
Archived
2026-11-09T03:06:19.196Z
SHA-256 of the archived text
53aade957f508c58e4ef7306f8c07736be4d263f45a1b6199f297cec5c102fb6
Stable URL of this page
https://metraipolis.com/documento/dc_ea5917e3ecb0

How to cite

Modulatory efficacy of bone metabolism and safety of denosumab versus zoledronic acid in the treatment of bone and joint osteoporosis in elderly men — Europe PMC PMID:41208862 — Europe PMC (en), https://europepmc.org/article/MED/41208862 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ea5917e3ecb0 (Metraipolis archive dc_ea5917e3ecb0, sha256 53aade957f508c58e4ef7306f8c07736be4d263f45a1b6199f297cec5c102fb6)
BibTeX
@misc{dcea5917e3ecb0,
  title = {Modulatory efficacy of bone metabolism and safety of denosumab versus zoledronic acid in the treatment of bone and joint osteoporosis in elderly men — Europe PMC PMID:41208862},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41208862},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ea5917e3ecb0; sha256 53aade957f508c58e4ef7306f8c07736be4d263f45a1b6199f297cec5c102fb6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41208862. Agents can read the archived copy with the MCP tool read_document.